Drug, Biomolecule, and Vaccine Delivery

Materials for Drug & Gene Delivery

Symposium Chair

Helen Zha
Assistant Professor
Rensselaer Polytechnic Institute

Key Speakers

Molecular Engineering for On-Demand Therapeutic Delivery
Matthew Webber
Associate Professor, Notre Dame University

Fractomers: Harnessing Intrinsically Disordered Proteins for Next-Generation Biomaterial Development
Stefan Roberts
CEO, Insoma Bio

Presentations in this session focus on strategies for improving the delivery of traditional small molecule drugs, proteins such as monoclonal antibodies, or genetic material (RNA, DNA). The route of administration can be systemic (e.g., IV, oral) or local (e.g., IM, topical), with the goal of enhancing delivery beyond current approaches. The delivery improvement can be in terms of timing, control, or dosing, but may also address challenges associated with biological responses to the delivery vehicle such as toxicity and immunogenicity.

Back to Top ↑ 2024 Symposium Sessions
	Monday June 17
4:00	Drug Delivery - Posters
	Tuesday June 18
9:15	Molecular Engineering & Nanoparticle Design for Drug Delivery II

2024 Symposium Program
	Monday June 17

4:00	Drug Delivery - Posters	Expo Hall BC
	Precision without Radiation: Advanced Needle Guidance Technology for Percutaneous Needle Interventions P. Vemavarapu, XRMedix, US
	Nanotechnology driven turmeric nanoformulation with enhanced functionality R. Kaur, Punjabi University Patiala, IN
	SynerGene’s Versatile Platform Technology for Delivery of Diverse Molecules Into TfR-expressing Cells and Across the BBB J.B. Harford, S.S. Kim, M. Moghe, A.S. Rait, K.F. Pirollo, E.H. Chang, SynerGene Therapeutics, Inc., US
	Feasibility Assessment through Visco-Elasticity Measurement of High-Concentration Formulation C. Kim, D.A. Weitz, and W. Jhe, Seoul National University, KR
	Tuesday June 18

9:15	Molecular Engineering & Nanoparticle Design for Drug Delivery II	TBA
	Session chair: R. Helen Zha, Rensselaer Polytechnic Institute & Jeannine Coburn, Worcester Polytechnic Institute, US
9:15	Molecular Engineering for On-Demand Therapeutic Delivery M.J. Webber, University of Notre Dame, US
9:45	Fractomers: Harnessing Intrinsically Disordered Proteins for Next-Generation Biomaterial Development S. Roberts, S. Hollenbeck, A. Chilkoti, inSoma Bio, Inc., US
10:15	Delivery of Therapeutic Plant-Derived Exosomes to the Brain for the Treatment of Mental Health Disorders and CNS Injuries N. NassiriKoopaei, EriVan Bio and University of Florida, US
10:35	OcuHeal UV-400+ : Ophthalmic, UV-blocking, Anti-oxidant, Preservative-free Nanolipid Eye-drop S.P. Barman, K. Barman, S. Harris, K. Ward, Symphony Therapeutics (subsidiary of Integral BioSystems), US
10:55	A Novel Compound to Reverse the Effects of Drugs of Abuse and Neuromuscular Blocking Agents E. Broyles, L. Isaacs, Reversal Therapeutics, Inc., US
11:15	Interfacial Assembly of Silk Fibroin for Controlled Biopharmaceutical Release R.H. Zha, T.D. Fink, C. Wigham, Rensselaer Polytechnic Institute, US